Combined Therapy of Yishen Zhuanggu Decoction and Caltrate D600 Alleviates Postmenopausal Osteoporosis by Targeting FoxO3a and Activating the Wnt/β-Catenin Pathway

BACKGROUND: Postmenopausal osteoporosis (PMO) is the most prevalent metabolic bone disease in women. Yishen Zhuanggu (YSZG) decoction and Caltrate D600 reportedly affects bone formation. This study aimed to investigate the efficacy and mechanism of YSZG decoction combined with Caltrate D600 in PMO t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bole, Jiang, Changqing, Zhan, Xinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307327/
https://www.ncbi.nlm.nih.gov/pubmed/35873637
http://dx.doi.org/10.1155/2022/7732508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307327/
https://www.ncbi.nlm.nih.gov/pubmed/35873637
http://dx.doi.org/10.1155/2022/7732508

Ejemplares similares